We represented Evolent Health, Inc. (NYSE:EVH), a healthcare technology solution for complex health conditions, in its acquisition of certain assets of Machinify Inc., a software platform that leverages artificial intelligence to increase quality, speed and consistency of clinical reviews, for cash consideration of $19.5 million, plus an earn-out of up to $12.5 million.